Loading...
OTCM
BTAX
Market cap8kUSD
Jun 22, Last price  
0.00USD
Name

Immune Therapeutics Inc

Chart & Performance

D1W1MN
OTCM:BTAX chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
157.47%
Rev. gr., 5y
134.52%
Revenues
0k
00016,1973,4630113,5000000
Net income
-6m
L
-174,989,000-106,060,000-48,253,000-16,314,000-19,521,000-7,316,000-8,175,000-4,673,0001,109,0003,586,000-5,788,000
CFO
-582k
L+151.09%
-908,483-6,570,832-3,843,095-2,832,313-2,839,739-2,053,263-1,369,503-934-191,954-231,717-581,821

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc., the company adopted its present name in October 2014. Its corporate headquarters are situated in Orlando, Florida.
URL
https://www.immunetherapeutics.com/
IPO date
Jul 16, 2001
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT